Drug intelligence / Profile preview

BAT2020

Development stage: Discontinued
Lead developer: Bio-Thera Solutions
Administration: Intravenous

Overview

BAT2020 is an investigational drug developed by Bio-Thera Solutions as an intravenous infusion for the treatment of COVID-19 infections. The development status of BAT2020 has been reported as discontinued, and it was being explored in the therapeutic area of infectious diseases. Detailed information about its mechanism of action, molecular modality, or specific targets has not been disclosed in public sources[1][2].

Beyond the preview

Go deeper on BAT2020.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAT2020.

Explore the full profile